Forghani Foroogh, Masoodi Mohsen, Kadivar Maryam
Colorectal Research Center, Department of Gastroenterology, Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Department of Pathology, Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Oman Med J. 2017 Jul;32(4):335-338. doi: 10.5001/omj.2017.63.
Primary hepatic lymphoma (PHL) presenting with obstructive jaundice is rare and can mimic a preoperative diagnosis of cholangiocarcinoma. We should consider PHL in patients with radiological hepatic disease with normal serum alpha-fetoprotein and carcinoembryonic antigen levels, and elevated lactate dehydrogenase. We present the case of a 67-year-old male with no significant medical history presented with abdominal pain, jaundice, fever, and abnormal liver function tests. Abdominal sonography and computed tomography scan suggested a diagnosis of obstructive jaundice and cholangitis due to cholangiocarcinoma (Klatskin tumor). A subsequent liver biopsy diagnosed PHL, and the patient was treated with combination chemotherapy, including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). PHL should be considered in patients presenting with biliary obstruction.
以梗阻性黄疸为表现的原发性肝淋巴瘤(PHL)较为罕见,术前可能被误诊为胆管癌。对于血清甲胎蛋白和癌胚抗原水平正常、乳酸脱氢酶升高的肝脏影像学疾病患者,应考虑PHL。我们报告一例67岁男性患者,既往无重大病史,出现腹痛、黄疸、发热及肝功能检查异常。腹部超声和计算机断层扫描提示诊断为胆管癌(Klatskin瘤)所致的梗阻性黄疸和胆管炎。随后的肝脏活检确诊为PHL,患者接受了包括利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松(R-CHOP)的联合化疗。对于出现胆道梗阻的患者,应考虑PHL。